Have We Lost the Cannabis Legalization War?

Listen to Dr. Kevin Sabet’s discussion on High Truths on
Drugs and Addiction, Episode #23

Have we lost the cannabis legalization war? This is a question posed to Dr. Kevin Sabet, IASIC Advisor, former White House Advisor, and president and CEO of SAM, Smart Approaches to Marijuana. Listen to his expertise on High Truths on Drugs and Addiction, Episode #23.

Is there even a war on drugs anymore? How can people in prevention go against a billion-dollar marijuana goliath industry? Dr. Sabet has a thoughtful conversation with Dr. Roneet Lev on High Truths.

Listen Now

About Kevin Sabet, PhD
An affiliate of the Institution for Social and Policy Studies and the Medical School at Yale University, and dubbed by NBC News as the “prodigy of drug politics,” author, consultant, and advisor to three U.S. presidential administrations, Kevin A. Sabet, Ph.D., has studied, researched, written about, and implemented drug policy for 25 years. He is currently the President and CEO of SAM (Smart Approaches to Marijuana), a non-profit organization he founded with Congressman Patrick Kennedy and David Frum. His latest book, Smokescreen: What the Marijuana Industry Doesn’t Want You to Know, is distributed by Simon & Schuster. He is the only person appointed by Republicans and Democrats to work at the White House drug office, and he is a columnist for Newsweek. He received his doctorate from Oxford University.

Listen to Episode #23 Now

For more information on the International Academy on the Science and Impact of Cannabis, and to join, please visit www.IASIC1.org

Visit the IASIC Library here. The IASIC Library is intended as a user-friendly reference of the published medical literature.

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Leave a comment

Related Posts

Major Uptick Reported in Cannabis Vaping for All Adolescents

Cannabis vaping is increasing as the most popular method of cannabis delivery among all adolescents in the U.S., as is the frequency of cannabis vaping, according to research at Columbia University Mailman School of Public Health. The study found that the frequency of vaping cannabis among adolescents from all demographic groups is reported at six

The phytochemical diversity of commercial Cannabis in the United States

The legal status of Cannabis is changing, fueling an increasing diversity of Cannabis-derived products. Because Cannabis contains dozens of chemical compounds with potential psychoactive or medicinal effects, understanding this phytochemical diversity is crucial. The legal Cannabis industry heavily markets products to consumers based on widely used labeling systems purported to predict the effects of different

What is THCP?

THCP, which is short for tetrahydrocannabiphorol and scientifically known as (-)-Trans-Δ9-tetrahydrocannabiphorol, is a natural cannabinoid and analog of THC present in varieties of cannabis. It’s thought to be 33 times more active at cannabinoid 1 (CB1) receptors than THC, causing an intense and intoxicating euphoric high. THCP’s legality is stuck between conflicting federal legislation. It’s not

Cannabis Legalization and Detection of Tetrahydrocannabinol (THC) in Injured Drivers

A recent study funded by the Canadian Institutes of Health Research found that after cannabis legalization, the prevalence of moderately injured drivers with a THC level of at least 2 ng per milliliter in participating British Columbia trauma centers more than doubled. The increase was largest among older drivers and male drivers. During the study

Scroll to Top